U.S. Biotech Stock News

HEICO (HEI) has been drawing attention after reporting record results across multiple recent quarters. These results have been supported by organic growth, acquisitions in its Flight Support and Electronic Technologies groups, and a growing missile defense order backlog. See our latest analysis for HEICO. At a share price of $347.7, HEICO has seen firm upward momentum recently, with a 30-day share price return of 11.37% and a 1-year total shareholder return of 54.06%, pointing to strong...

If you are wondering whether Ecolab’s current share price really matches what you are getting as an investor, this article walks through the key numbers so you can judge value for yourself. Ecolab’s stock recently closed at US$271.53, with returns of 2.7% over 7 days, 4.6% over 30 days, 3.4% year to date, 18.5% over 1 year, 84.2% over 3 years and 28.5% over 5 years that many investors may want to put in context. Recent news coverage around Ecolab has largely focused on its role in water,...

Euna Solutions previously announced that its Euna Marketplace, a Workday Certified Integration tailored for public-sector procurement, is now available on the Workday Marketplace, allowing Workday users to shop approved supplier catalogs within Euna’s AI-enabled platform and complete purchases back in Workday. This deeper connection between Workday and a specialized public-sector procurement platform underscores how Workday’s ecosystem approach can extend its applications into regulated,...

Today we're going to take a look at the well-established Warner Music Group Corp. ( NASDAQ:WMG ). The company's stock...

Insiders who bought US$3.82m worth of Mercer International Inc. ( NASDAQ:MERC ) stock in the last year have seen some...

Anyone interested in Rapport Therapeutics, Inc. ( NASDAQ:RAPP ) should probably be aware that the Founder & Chief...

If you are wondering whether Ellington Financial at around US$13.53 is offering good value today, you are not alone. This article is designed to walk you through that question step by step. The stock has had a mixed short term run, with returns of a 1.6% decline over 7 days, a 1.4% decline over 30 days and a 1.1% decline year to date. The longer term picture shows 24.4% over 1 year, 51.1% over 3 years and 62.1% over 5 years. Recent attention on Ellington Financial has centered around its...

Lennox International (LII) is back in focus after weaker Q3 results, with year-on-year revenue declines, an earnings miss, and management describing 2025 as a transitional year shaped by refrigerant changes and tougher macroeconomic conditions. See our latest analysis for Lennox International. The share price has been volatile around these updates, with a 3.2% 1 day share price return and 5.2% 7 day share price return, but a 6.3% 90 day share price decline and a 14.1% 1 year total shareholder...

Why Darden’s updated outlook caught investors’ attention Darden Restaurants (DRI) lifted its full year sales guidance after reporting steady demand across its brands, especially Olive Garden, and pointing to market share gains versus both casual dining peers and limited service rivals. See our latest analysis for Darden Restaurants. The updated outlook comes on top of a recent run in the shares, with a 30 day share price return of 12.68% and a 1 year total shareholder return of 11.92%. This...

You might be wondering whether Altria Group's current share price still offers value, or if most of the opportunity has already been priced in. The stock last closed at US$55.16, with recent returns of a 4.5% decline over 7 days, a 4.9% decline over 30 days, a 3.8% decline year to date, a 14.9% gain over 1 year, a 52.3% gain over 3 years and a 99.0% gain over 5 years. Recent attention around Altria Group has focused on its position in the tobacco and nicotine market and how its product mix...

UMB Financial (UMBF) is back in focus after fresh data highlighted strong market share gains, a 17.8% annual rise in net interest income over five years and 20.4% annual earnings per share growth. See our latest analysis for UMB Financial. The recent fundamentals story has been met with a firmer share price, with UMB Financial now at $121.43 after a 5.65% 1 month share price return and a 72.74% 5 year total shareholder return. This suggests momentum has been building over time. If you are...

If you are wondering whether Pool's share price still reflects its underlying business, you are not alone. This article focuses on what the numbers say about value rather than short term excitement. Pool closed at US$239.38, with returns of 3.6% over the last 7 days, roughly flat at a 0.1% decline over 30 days, a 4.2% gain year to date, and longer term share price declines of 25.8% over 1 year, 23.3% over 3 years, and 34.1% over 5 years. These moves are set against a backdrop of ongoing...

If you have been wondering whether Baidu’s recent run makes it expensive or still interesting, this article will walk through what the current share price actually bakes in. The stock closed at US$146.42, with returns of 10.6% over the last 7 days, 16.5% over the last 30 days, and 77.2% over the last year. Year to date it is at a 2.6% decline, and the 5-year return sits at a 38.9% decline. These price moves sit against an ongoing stream of headlines around Chinese technology companies and...

Powell Industries (POWL) has drawn fresh attention after its shares moved 10.6% higher on the first U.S. trading day of 2026, with investors positioning in advance of an early February earnings update. See our latest analysis for Powell Industries. The early year move has come on top of a 9.9% 7 day share price return and a 14.1% 90 day share price return, while the 1 year total shareholder return of 52.5% and very large 3 and 5 year total shareholder returns suggest that momentum has been...

If you have been wondering whether Abbott Laboratories at around US$127.78 is offering fair value or a premium price, this breakdown is designed to give you a clear and structured view. The stock has recorded returns of 1.6% over the last 7 days, 2.2% over the last 30 days, 2.9% year to date, 14.8% over 1 year, 19.0% over 3 years, and 28.5% over 5 years, which many investors will weigh against current pricing. Recent attention on Abbott has centered on how its broad healthcare portfolio and...

Stock performance snapshot and business profile Evolv Technologies Holdings (EVLV) has been drawing attention after recent trading moves, with the stock showing mixed short term returns, including gains over the past month alongside a decline over the past 3 months. The US based security technology company focuses on AI driven weapons detection systems for venues such as schools, hospitals, sports arenas, entertainment sites and industrial workplaces, supported by products like Evolv Express...

Advanced Energy Industries (AEIS) has drawn investor attention after being named Investor’s Business Daily’s Stock of the Day, following a technical breakout linked to its AI focused data center and Thailand manufacturing expansion story. See our latest analysis for Advanced Energy Industries. That breakout sits on top of strong recent momentum, with a 90 day share price return of 31.32% and a 1 year total shareholder return of 83.94%, while the latest close is US$229.70. Taken together, this...

At CES 2026, Maplebear (CART), which operates as Instacart, introduced Data Hub, a clean room tool that lets consumer brands combine their own data with Instacart grocery purchase signals. See our latest analysis for Maplebear. The Data Hub launch comes as Maplebear trades at US$44.42 per share, with a 90 day share price return of 12.03% and a 1 year total shareholder return of 3.52%. This suggests recent momentum has been building rather than fading. If this kind of data focused story has...

Tuya (NYSE:TUYA) has begun a shareholder-authorized share repurchase program, allowing buybacks of up to 60,972,194 shares, or 10% of issued capital, aimed at supporting net assets and earnings per share. See our latest analysis for Tuya. Tuya’s latest share repurchase plan comes after a mixed pattern in its share price, with a 7 day share price return of 5.14% but a 90 day share price return of 12.79%. At the same time, the 1 year total shareholder return of 40.65% points to stronger longer...

T1 Energy (TE) recently moved to comply with the One Big Beautiful Bill Act by cutting foreign ownership tied to Trina Solar, revising its certificate of incorporation, and preserving access to key clean energy tax credits. See our latest analysis for T1 Energy. T1 Energy’s recent compliance moves come after a sharp run, with a 90 day share price return of 161.09% and a 30 day gain of 31.22%, even though the year to date share price return is slightly negative and the 3 year total shareholder...

Recent discussion around West Pharmaceutical Services (WST) has centered on declining adjusted operating margins and slower revenue growth versus healthcare peers, as rising competition and higher expenses pressure profitability and leave investors more cautious about the current valuation. See our latest analysis for West Pharmaceutical Services. Those margin concerns are landing at a time when the share price has moved only modestly, with a 90 day share price return of 4.81% and a 1 year...

Kenvue (KVUE) has been drawing investor interest after recent share price moves, with the stock closing at $16.75. That puts the consumer health company’s performance under closer scrutiny against its fundamentals. See our latest analysis for Kenvue. The recent pullback, including a 1 day share price return of 0.42% and a 7 day share price return of 3.35%, comes against a 1 year total shareholder return of 17.13%. This suggests that recent momentum has been fading after earlier weakness. If...

Why Sarepta Therapeutics is on investors’ radar today Sarepta Therapeutics (SRPT) has drawn fresh attention after recent trading left the stock at a last close of $22.35, reflecting mixed short term returns and weaker performance over the past year and the past 3 months. See our latest analysis for Sarepta Therapeutics. For Sarepta, the recent 6.08% 1-day share price return and 3.86% 7-day share price return sit against a much weaker backdrop, with a 1-year total shareholder return decline of...

If you are wondering whether USA Rare Earth is priced fairly or whether the recent buzz has left value on the table, this article walks through what the numbers say about the stock. At a last close of US$17.52, USA Rare Earth has posted returns of 44.4% over the past week, 1.7% over the last month, 23.8% year to date, and 31.0% over the past year. These moves raise questions about how sentiment lines up with underlying value. Recent attention around USA Rare Earth has been driven by ongoing...